Disparities in Cancer Outcomes Due to COVID-19—A Tale of 2 Cities
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes the disease coronavirus 2019 (COVID-19), has ravaged the United States since the first case was documented in Washington State in January 2020. By early March, the first case of COVID-19 was confirmed in New York. From the very first case to present day, it has become increasingly clear that densely populated cities bear the brunt of this disease. In New York City as of July 7, 2020, approximately 214?000 cases and 18?000 deaths have been documented. While COVID-19 has had a worldwide impact, suspicions about its disproportionate effects on minority populations have now been confirmed with the release of data stratified by race and ethnicity. Within New York, we are witnessing 2 distinct trajectories and risk groups defined along the lines of race and socioeconomic status. As of July 7, 2020, the age-adjusted death rate for Hispanic and Black patients is twice that of White patients.1 Additionally, the Bronx, Queens, and Brooklyn each have twice the number of cases per 100?000 individuals as Manhattan and 3 to 4 times the number of cases as Staten Island. The reasons for these disparities have been discussed at length and include rates of preexisting comorbidities, a majority of the population employed in essential blue-collar jobs, living conditions, health literacy, and access to health care
JAMA Oncology , article en libre accès, 2019